Researchers are exploring the use of dendritic cell-based nanovaccines as a potential approach to cancer immunotherapy. This method involves utilizing dendritic cells, which play a key role in the immune system, in combination with nanotechnology to develop vaccines. The goal of this approach is to stimulate an immune response against cancer.